Fig. 4From: Robust pathway-based multi-omics data integration using directed random walks for survival prediction in multiple cancer studiesClassification performances of the iDRW method and four pathway-based methods with varying number of sample size N in breast cancer samples. Classification performances are shown with respect to the number of samples N which are 70, 80, 90, 100% out of whole samples. Performances are measured using precision, recall and F-1 score after 50 repeats of five-fold cross-validation in breast cancer dataBack to article page